A new trading day began on Friday, with Genprex Inc (NASDAQ: GNPX) stock price up 21.51% from the previous day of trading, before settling in for the closing price of $0.34. GNPX’s price has ranged from $0.28 to $14.80 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 75.40%. With a float of $2.43 million, this company’s outstanding shares have now reached $2.59 million.
Let’s look at the performance matrix of the company that is accounted for 26 employees. In terms of profitability, gross margin is 47.71%, operating margin of -113535.75%, and the pretax margin is -112905.8%.
Genprex Inc (GNPX) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Genprex Inc is 6.26%, while institutional ownership is 10.46%.
Genprex Inc (GNPX) Performance Highlights and Predictions
In its latest quarterly report, released on 6/30/2024, the company reported earnings of -5.2 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.68 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 75.40% per share during the next fiscal year.
Genprex Inc (NASDAQ: GNPX) Trading Performance Indicators
Here are Genprex Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.95.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -16.05, a number that is poised to hit -2.73 in the next quarter and is forecasted to reach -1.65 in one year’s time.
Technical Analysis of Genprex Inc (GNPX)
Genprex Inc (NASDAQ: GNPX) saw its 5-day average volume 2.04 million, a positive change from its year-to-date volume of 0.26 million. As of the previous 9 days, the stock’s Stochastic %D was 56.20%. Additionally, its Average True Range was 0.05.
During the past 100 days, Genprex Inc’s (GNPX) raw stochastic average was set at 3.48%, which indicates a significant decrease from 87.30% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 92.35% in the past 14 days, which was lower than the 115.30% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.5167, while its 200-day Moving Average is $2.8874. Nevertheless, the first resistance level for the watch stands at $0.4530 in the near term. At $0.4930, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.5560. If the price goes on to break the first support level at $0.3500, it is likely to go to the next support level at $0.2870. Assuming the price breaks the second support level, the third support level stands at $0.2470.
Genprex Inc (NASDAQ: GNPX) Key Stats
With a market capitalization of 1.07 million, the company has a total of 2,099K Shares Outstanding. Currently, annual sales are 0 K while annual income is -30,860 K. The company’s previous quarter sales were 0 K while its latest quarter income was -6,500 K.
